193 related articles for article (PubMed ID: 37714246)
1. Nanotechnology in coronary heart disease.
Guo J; Wang H; Li Y; Zhu S; Hu H; Gu Z
Acta Biomater; 2023 Nov; 171():37-67. PubMed ID: 37714246
[TBL] [Abstract][Full Text] [Related]
2. The Emergence of Nanotechnology in the Prognosis and Treatment of Myocardial Infarctions.
Sharma I; Bhardwaj S; Karwasra R; Kaushik D; Sharma S
Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904554
[TBL] [Abstract][Full Text] [Related]
3. Developments and Trends of Nanotechnology Application in Sepsis: A Comprehensive Review Based on Knowledge Visualization Analysis.
Fu J; Cai W; Pan S; Chen L; Fang X; Shang Y; Xu J
ACS Nano; 2024 Mar; 18(11):7711-7738. PubMed ID: 38427687
[TBL] [Abstract][Full Text] [Related]
4. Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of 1990-2022.
Zhang J; Ji C; Zhai X; Tong H; Hu J
Front Cardiovasc Med; 2023; 10():1038738. PubMed ID: 36873405
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
[TBL] [Abstract][Full Text] [Related]
6. Application of omics beyond the central dogma in coronary heart disease research: A bibliometric study and literature review.
Lim SY; Selvaraji S; Lau H; Li SFY
Comput Biol Med; 2022 Jan; 140():105069. PubMed ID: 34847384
[TBL] [Abstract][Full Text] [Related]
7. Coronary heart disease and gut microbiota: A bibliometric and visual analysis from 2002 to 2022.
Long D; Mao C; Zhang X; Liu Y; Shangguan X; Zou M; Zhu Y; Wang X
Front Cardiovasc Med; 2022; 9():949859. PubMed ID: 36158832
[TBL] [Abstract][Full Text] [Related]
8. Patient education in the management of coronary heart disease.
Anderson L; Brown JP; Clark AM; Dalal H; Rossau HK; Bridges C; Taylor RS
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008895. PubMed ID: 28658719
[TBL] [Abstract][Full Text] [Related]
9. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
Mohamed NA; Marei I; Crovella S; Abou-Saleh H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
[TBL] [Abstract][Full Text] [Related]
10. Advanced implications of nanotechnology in disease control and environmental perspectives.
Biswas P; Polash SA; Dey D; Kaium MA; Mahmud AR; Yasmin F; Baral SK; Islam MA; Rahaman TI; Abdullah A; Ema TI; Khan DA; Bibi S; Chopra H; Kamel M; Najda A; Fouda MMA; Rehan UM; Mheidat M; Alsaidalani R; Abdel-Daim MM; Hasan MN
Biomed Pharmacother; 2023 Feb; 158():114172. PubMed ID: 36916399
[TBL] [Abstract][Full Text] [Related]
11. A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases.
Liang Y; Liao S; Zhang X
Front Cardiovasc Med; 2022; 9():940769. PubMed ID: 35865387
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology in reproductive medicine: emerging applications of nanomaterials.
Barkalina N; Charalambous C; Jones C; Coward K
Nanomedicine; 2014 Jul; 10(5):921-38. PubMed ID: 24444494
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance imaging in coronary heart disease.
Bogaert J; Dymarkowski S; Rademakers FE
JBR-BTR; 2002; 85(2):57-81. PubMed ID: 12083625
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy.
Wahab S; Ghazwani M; Hani U; Hakami AR; Almehizia AA; Ahmad W; Ahmad MZ; Alam P; Annadurai S
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770883
[TBL] [Abstract][Full Text] [Related]
15. Cell membrane-based nanomaterials for theranostics of central nervous system diseases.
Li W; Cheng J; He F; Zhang P; Zhang N; Wang J; Song Q; Hou Y; Gan Z
J Nanobiotechnology; 2023 Aug; 21(1):276. PubMed ID: 37596631
[TBL] [Abstract][Full Text] [Related]
16. Advances in Nanotechnology for the Treatment of Osteoporosis.
Barry M; Pearce H; Cross L; Tatullo M; Gaharwar AK
Curr Osteoporos Rep; 2016 Jun; 14(3):87-94. PubMed ID: 27048473
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
[TBL] [Abstract][Full Text] [Related]
18. Cancer Nanotechnology: Recent Trends and Developments in Strategies for Targeting Cancer Cells to Improve Cancer Imaging and Treatment.
Xu J; Zhou X; Li Y; Tian Y
Curr Drug Metab; 2017; 18(4):266-279. PubMed ID: 28093991
[TBL] [Abstract][Full Text] [Related]
19. Psychological interventions for coronary heart disease.
Richards SH; Anderson L; Jenkinson CE; Whalley B; Rees K; Davies P; Bennett P; Liu Z; West R; Thompson DR; Taylor RS
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002902. PubMed ID: 28452408
[TBL] [Abstract][Full Text] [Related]
20. Exercise-based cardiac rehabilitation for coronary heart disease.
Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
